Mackenzie Financial’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Sell |
53,357
-5,022
| -9% | -$108K | ﹤0.01% | 980 |
|
|
2025
Q1 | $970K | Buy |
58,379
+7,314
| +14% | +$121K | ﹤0.01% | 991 |
|
|
2024
Q4 | $937K | Buy |
51,065
+32,833
| +180% | +$602K | ﹤0.01% | 954 |
|
|
2024
Q3 | $280K | Sell |
18,232
-1,668
| -8% | -$25.7K | ﹤0.01% | 1223 |
|
|
2024
Q2 | $323K | Sell |
19,900
-37,839
| -66% | -$615K | ﹤0.01% | 1144 |
|
|
2024
Q1 | $1.07M | Buy |
57,739
+4,760
| +9% | +$88K | ﹤0.01% | 860 |
|
|
2023
Q4 | $1.66M | Buy |
52,979
+39,460
| +292% | +$1.24M | ﹤0.01% | 763 |
|
|
2023
Q3 | $281K | Sell |
13,519
-10,143
| -43% | -$211K | ﹤0.01% | 1160 |
|
|
2023
Q2 | $568K | Buy |
23,662
+10,325
| +77% | +$248K | ﹤0.01% | 982 |
|
|
2023
Q1 | $251K | Sell |
13,337
-1,254
| -9% | -$23.6K | ﹤0.01% | 1255 |
|
|
2022
Q4 | $232K | Sell |
14,591
-19,221
| -57% | -$306K | ﹤0.01% | 1180 |
|
|
2022
Q3 | $553K | Sell |
33,812
-805
| -2% | -$13.2K | ﹤0.01% | 908 |
|
|
2022
Q2 | $488K | Buy |
34,617
+15,674
| +83% | +$221K | ﹤0.01% | 953 |
|
|
2022
Q1 | $459K | Buy |
18,943
+7,785
| +70% | +$189K | ﹤0.01% | 1004 |
|
|
2021
Q4 | $260K | Buy |
+11,158
| New | +$260K | ﹤0.01% | 1212 |
|